Related Experiment Video
Updated: Aug 11, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Parthenium dermatitis treated with azathioprine weekly pulse doses
Kaushal K Verma1, Arika Bansal, G Sethuraman
1Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India. prokverma@hotmail.com
Indian Journal of Dermatology, Venereology and Leprology
|February 17, 2006
Summary
Weekly pulse doses of azathioprine offer an effective and safe treatment for Parthenium dermatitis, significantly reducing disease severity. This approach lowers therapy costs by 60% without serious adverse effects.
Area of Science:
- Dermatology
- Immunosuppressive therapy
- Contact dermatitis
Background:
- Parthenium dermatitis is a significant health concern in India.
- Corticosteroids, while standard treatment, carry risks of severe side effects with prolonged use.
- Daily azathioprine has demonstrated efficacy in managing Parthenium dermatitis.
Purpose of the Study:
- To evaluate the effectiveness of weekly pulse doses of azathioprine for treating Parthenium dermatitis.
- To assess the safety and cost-effectiveness of this treatment regimen.
Main Methods:
- A study involving 12 patients (10 male, 2 female) with a history of Parthenium dermatitis.
- Diagnosis confirmed via patch testing; disease severity assessed using a clinical severity score (CSS).
- Treatment involved 300 mg of azathioprine once weekly for 6 months, with regular clinical and laboratory evaluations.
Main Results:
- Excellent response (80-100% clearance) in 58.33% of patients; good response (60% clearance) in 41.66%.
- Mean CSS significantly decreased from 40.4 +/- 7.95 to 10.9 +/- 8.43 (P = 0.002).
- No significant adverse side effects were reported during the treatment period.
Conclusions:
- Weekly pulse azathioprine is effective and safe for Parthenium dermatitis treatment in this preliminary study.
- This regimen offers a substantial cost reduction of 60% compared to other treatments.
- Further research may validate these findings for broader clinical application.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:25Pericarditis IV: Nursing Management
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.